Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein

  • Sharad P. Adekar,

    Affiliations Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States of America, Immunome, Inc., Wynnewood, Pennsylvania, United States of America, Augmenta Biologicals, LLC, Wynnewood, Pennsylvania, United States of America

    ⨯
  • Andrew T. Segan,

    Affiliation Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States of America

    ⨯
  • Cindy Chen,

    Affiliation Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States of America

    ⨯
  • Rodney Bermudez,

    Affiliation Immunome, Inc., Wynnewood, Pennsylvania, United States of America

    ⨯
  • M. D. Elias,

    Affiliation Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    ⨯
  • Bernard H. Selling,

    Affiliation Impact Biologicals, Inc. Wallingford, Pennsylvania, United States of America

    ⨯
  • B. P. Kapadnis,

    Affiliation Department of Microbiology, University of Pune, Pune, India

    ⨯
  • Lance L. Simpson,

    Affiliation Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    ⨯
  • Paul M. Simon ,

    scott.dessain@gmail.com (SKD); simonpm@augmentabio.com (PMS)

    Affiliation Augmenta Biologicals, LLC, Wynnewood, Pennsylvania, United States of America

    ⨯
  • Scott K. Dessain

    scott.dessain@gmail.com (SKD); simonpm@augmentabio.com (PMS)

    Affiliation Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States of America

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.